In a speech in a town hall meeting at Clafin University, South Carolina, Democratic presidential candidate Hillary Clinton called for marijuana restrictions to be reclassified from a Schedule 1 drug to a Schedule 2 drug by the federal government, opening the door for research on it’s medical use.
“I do support the use of medical marijuana,” Clinton said at a town hall meeting at Claflin University in Orangeburg, South Carolina. “And I think even there we need to do a lot more research so that we know exactly how we’re going to help people for whom medical marijuana provides relief.”
During the Democratic Presidential debate in October, Clinton did not take a position on federal policy regarding the legalization of cannabis. In response to a question about the drug at the town hall, in a direct rebuttal to her earlier position, Clinton said, “We haven’t done research, why? Because it’s considered a schedule 1 drug.” “I’d like to move it from schedule 1 to schedule 2.”
Marijuana is classified a Schedule 1 drug by the Drug Enforcement Administration, which means it is considered among the most dangerous group of drugs carrying a high potential for abuse and addiction. Drugs in the group include heroin and cocaine. The scheduling makes it difficult to conduct research on marijuana, despite it being legalized in several states for both medical and recreational use.
In response to other questions regarding cannabis research Clinton said, “If we’re going to have a lot of states setting up marijuana dispensaries so that people who have some kind of medical need are getting marijuana, we need to know what’s the quality of it, how much should you take, what should you avoid if you’re taking other medications.”
During the Democratic presidential debate in October, the former Secretary of State expressed support for research on medical uses for marijuana in states that have legalized it medicinally but did not state an opinion on federal marijuana policy.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of PotNetwork.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://potnetwork.com/legal-disclaimer/.